Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction
about
Clinical Implications of Glucose Variability: Chronic Complications of DiabetesLixisenatide as add-on therapy to basal insulinGlycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina.The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c.Utility of different glycemic control metrics for optimizing management of diabetesPharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized PatientsGlycemic variability in normal glucose tolerance women with the previous gestational diabetes mellitus.An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Acute Myocardial Infarction.Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin.Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention.Hyperglycemia at presentation is associated with in hospital mortality in non-diabetic patient with organophosphate poisoning.Glycemic control in the critically ill: What have we learned since NICE-SUGAR?The Development of New Composite Metrics for the Comprehensive Analytic and Visual Assessment of Hypoglycemia Using the Hypo-Triad.Hyperglycemia and Acute Kidney Injury During the Perioperative Period.Effects of the Mean Amplitude of Glycemic Excursions and Vascular Endothelial Dysfunction on Cardiovascular Events in Nondiabetic Patients With Coronary Artery Disease.Early glucose variability in cardiogenic shock following acute myocardial infarction: a pilot study.The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetesDifferent levels of glycosylated hemoglobin influence severity and long-term prognosis of coronary heart disease patients with stent implantation.Admission hyperglycemia predicts inhospital mortality and major adverse cardiac events after primary percutaneous coronary intervention in patients without diabetes mellitus.Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus.Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.Comparison of the relationship between multiple parameters of glycemic variability and coronary plaque vulnerability assessed by virtual histology-intravascular ultrasound.Glycemic excursions are positively associated with HbA1c reduction from baseline after treatment with acarbose in patients with type 2 diabetes on metformin monotherapy.Analysis of Postprandial Glycemia in Relation to Metabolic Compensation and Other Observed Parameters of Outpatients with Type 2 Diabetes Mellitus in the Czech Republic.Effectiveness, safety and feasibility of an evidence-based insulin infusion protocol targeting moderate glycaemic control in intensive cardiac care units.Diabetes, cardiovascular disease and the microcirculation.Admission glycemic variability correlates with in-hospital outcomes in diabetic patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus
P2860
Q26801671-D07E2C7A-3126-4A23-80CC-4B1C7E2B0207Q27007547-03439846-2EDB-472F-A02C-682B759037BDQ33804317-CD63041E-7D18-44A3-B394-A5380E4E1F49Q34748572-2ADC5C5F-D0B4-4579-B009-BE1DF5E734B9Q35049855-C7F7E283-2192-402B-AEAB-F4DCA61A9C3DQ35912987-656495F7-356F-4D92-B5E5-BB4766473C40Q36088149-1CF9A0F6-8165-4576-9171-54AA7B9BEA3CQ36996153-BF48594F-0705-4ECF-9062-77F56737A32CQ37621228-9C7D2F35-1360-4645-90A0-DAD5BBAAC2A9Q37713552-41D3031B-2D01-4E06-994B-40AE6B2C035AQ38418242-93150A77-A457-41B5-9F29-00C4DF553DEEQ38557229-0776C8FE-54F9-4442-9415-38F05CD7A945Q38658266-B27650DF-58A4-4CB2-BB72-EDF37007324BQ38704977-B3BF7BBE-53E2-4184-93FD-A445DF480BC7Q41104232-BA161991-C8CF-4382-B296-0FF5129447FBQ41157755-2009ACEB-FE3A-46B7-AF82-26F0DFA52F93Q41533654-6BECD1F8-A76B-4598-97D9-E2C0B2746DA3Q43086789-D6C86042-BD36-439D-A9F5-FBACD3640EAEQ45843323-AC6EA2CF-026E-4514-9B41-52F6670A69A1Q47098884-9C7A4EB8-6E26-485E-B84B-9D7EF636F3B9Q47944088-059A43F4-25A7-46DF-8A3B-4C7F296DB1D3Q47968543-9EF473E2-6816-4085-8124-795D99AD7C22Q48059208-8CC98298-389B-480F-8D9C-EF86F88556D3Q49824036-762133A1-12E3-490D-8035-2430B7438147Q53300768-95EDC72B-2CC3-4F53-AF16-5654607E199BQ54986438-DD70126E-967B-4AA5-9C5A-D3E600B767BBQ55287380-AE8AB187-28CD-4585-84A3-EA96B21F8123Q58737185-02EDFEF2-69BC-4854-9433-03F1F44CC266
P2860
Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Impact of admission glycemic v ...... er acute myocardial infarction
@ast
Impact of admission glycemic v ...... er acute myocardial infarction
@en
type
label
Impact of admission glycemic v ...... er acute myocardial infarction
@ast
Impact of admission glycemic v ...... er acute myocardial infarction
@en
prefLabel
Impact of admission glycemic v ...... er acute myocardial infarction
@ast
Impact of admission glycemic v ...... er acute myocardial infarction
@en
P2093
P2860
P356
P1433
P1476
Impact of admission glycemic v ...... er acute myocardial infarction
@en
P2093
Hong Zheng
Hong-Xia Yang
Shu-hua Mi
P2860
P304
P356
10.2337/DC12-0925
P407
P577
2013-01-24T00:00:00Z